Copyright Reports & Markets. All rights reserved.

Global Regenerative Therapies for Osteoarthritis Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Cell Therapy
      • 1.4.3 Tissue Engineering
      • 1.4.4 Gene Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Regenerative Therapies for Osteoarthritis Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centers
      • 1.5.4 Orthopaedic Clinics
      • 1.5.5 Research Institutes
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Regenerative Therapies for Osteoarthritis Market Size
    • 2.2 Regenerative Therapies for Osteoarthritis Growth Trends by Regions
      • 2.2.1 Regenerative Therapies for Osteoarthritis Market Size by Regions (2014-2025)
      • 2.2.2 Regenerative Therapies for Osteoarthritis Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Regenerative Therapies for Osteoarthritis Market Size by Manufacturers
      • 3.1.1 Global Regenerative Therapies for Osteoarthritis Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
    • 3.2 Regenerative Therapies for Osteoarthritis Key Players Head office and Area Served
    • 3.3 Key Players Regenerative Therapies for Osteoarthritis Product/Solution/Service
    • 3.4 Date of Enter into Regenerative Therapies for Osteoarthritis Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Regenerative Therapies for Osteoarthritis Market Size by Type (2014-2019)
    • 4.2 Global Regenerative Therapies for Osteoarthritis Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
    • 5.2 Regenerative Therapies for Osteoarthritis Key Players in United States
    • 5.3 United States Regenerative Therapies for Osteoarthritis Market Size by Type
    • 5.4 United States Regenerative Therapies for Osteoarthritis Market Size by Application

    6 Europe

    • 6.1 Europe Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
    • 6.2 Regenerative Therapies for Osteoarthritis Key Players in Europe
    • 6.3 Europe Regenerative Therapies for Osteoarthritis Market Size by Type
    • 6.4 Europe Regenerative Therapies for Osteoarthritis Market Size by Application

    7 China

    • 7.1 China Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
    • 7.2 Regenerative Therapies for Osteoarthritis Key Players in China
    • 7.3 China Regenerative Therapies for Osteoarthritis Market Size by Type
    • 7.4 China Regenerative Therapies for Osteoarthritis Market Size by Application

    8 Japan

    • 8.1 Japan Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
    • 8.2 Regenerative Therapies for Osteoarthritis Key Players in Japan
    • 8.3 Japan Regenerative Therapies for Osteoarthritis Market Size by Type
    • 8.4 Japan Regenerative Therapies for Osteoarthritis Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
    • 9.2 Regenerative Therapies for Osteoarthritis Key Players in Southeast Asia
    • 9.3 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Type
    • 9.4 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Application

    10 India

    • 10.1 India Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
    • 10.2 Regenerative Therapies for Osteoarthritis Key Players in India
    • 10.3 India Regenerative Therapies for Osteoarthritis Market Size by Type
    • 10.4 India Regenerative Therapies for Osteoarthritis Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Regenerative Therapies for Osteoarthritis Market Size (2014-2019)
    • 11.2 Regenerative Therapies for Osteoarthritis Key Players in Central & South America
    • 11.3 Central & South America Regenerative Therapies for Osteoarthritis Market Size by Type
    • 11.4 Central & South America Regenerative Therapies for Osteoarthritis Market Size by Application

    12 International Players Profiles

    • 12.1 Acelity
      • 12.1.1 Acelity Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.1.4 Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.1.5 Acelity Recent Development
    • 12.2 Mesoblast
      • 12.2.1 Mesoblast Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.2.4 Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.2.5 Mesoblast Recent Development
    • 12.3 Nuo Therapeutics
      • 12.3.1 Nuo Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.3.4 Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.3.5 Nuo Therapeutics Recent Development
    • 12.4 Astellas Pharma
      • 12.4.1 Astellas Pharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.4.4 Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.4.5 Astellas Pharma Recent Development
    • 12.5 Organovo
      • 12.5.1 Organovo Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.5.4 Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.5.5 Organovo Recent Development
    • 12.6 Orgenesis
      • 12.6.1 Orgenesis Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.6.4 Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.6.5 Orgenesis Recent Development
    • 12.7 Sanofi
      • 12.7.1 Sanofi Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.7.4 Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.7.5 Sanofi Recent Development
    • 12.8 Athersys
      • 12.8.1 Athersys Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.8.4 Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.8.5 Athersys Recent Development
    • 12.9 Shire
      • 12.9.1 Shire Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.9.4 Shire Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.9.5 Shire Recent Development
    • 12.10 Cytori Therapeutics
      • 12.10.1 Cytori Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Regenerative Therapies for Osteoarthritis Introduction
      • 12.10.4 Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2014-2019)
      • 12.10.5 Cytori Therapeutics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.
      The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market.
      In 2018, the global Regenerative Therapies for Osteoarthritis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Regenerative Therapies for Osteoarthritis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Regenerative Therapies for Osteoarthritis development in United States, Europe and China.

      The key players covered in this study
      Acelity
      Mesoblast
      Nuo Therapeutics
      Astellas Pharma
      Organovo
      Orgenesis
      Sanofi
      Athersys
      Shire
      Cytori Therapeutics

      Market segment by Type, the product can be split into
      Cell Therapy
      Tissue Engineering
      Gene Therapy

      Market segment by Application, split into
      Hospitals
      Ambulatory Surgical Centers
      Orthopaedic Clinics
      Research Institutes

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Regenerative Therapies for Osteoarthritis status, future forecast, growth opportunity, key market and key players.
      To present the Regenerative Therapies for Osteoarthritis development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Regenerative Therapies for Osteoarthritis are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now